Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,425,457
+$874,672 QoQ
Shares Held
17,744
+12.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#717
of 3,138 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $133,198,589 across 14 Drug Manufacturers - General names. AMGN ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
37,313 | $44,754,335 | |
| 2 | ABBV |
AbbVie Inc.
|
111,476 | $28,051,820 | |
| 3 | JNJ |
Johnson & Johnson
|
90,574 | $23,003,078 | |
| 4 | MRK |
Merck & Co., Inc.
|
81,333 | $10,451,290 | |
| 5 | AMGN |
Amgen Inc
This page
|
17,744 | $6,425,457 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
39,409 | $4,978,933 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
67,767 | $3,904,734 | |
| 8 | PFE |
Pfizer Inc
|
152,791 | $3,679,207 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,425,457 | 17,744 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,550,785 | 15,776 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $5,000,314 | 15,277 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $4,610,301 | 16,337 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,363,773 | 15,629 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $4,783,850 | 15,355 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $4,208,032 | 16,145 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $4,159,408 | 12,909 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,979,363 | 12,736 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,467,566 | 12,196 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,433,486 | 11,921 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $3,197,168 | 11,896 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,709,532 | 12,204 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,551,429 | 10,554 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,677,352 | 10,194 | Shares | Sole | 2023-05-01 | |
| 2022-09-30 | $1,856,169 | 8,235 | Shares | Sole | 2022-12-13 | |
| 2022-06-30 | $1,944,453 | 7,992 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,846,779 | 7,637 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,608,085 | 7,148 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $2,011,181 | 8,251 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $2,044,720 | 8,218 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,680,255 | 7,308 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $802,637 | 3,158 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $637,293 | 2,702 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $450,060 | 2,220 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||